Core Insights - The company has made significant progress in the commercialization of AI large models and intelligent agents, covering various sectors in the health industry, including marketing, healthcare, pharmacies, and consumer management [1][2] Group 1: Marketing - The company has launched the "AI Marketing Laboratory" and introduced the "Tian Gong No. 1 Commercial Intelligent Agent," providing "+AI" digital solutions to 182 pharmaceutical companies, enabling rapid response and efficient decision-making in a changing environment [1] Group 2: Healthcare - Utilizing its self-developed "Zhuo Mu Niao Medical Large Model," the company has introduced the intelligent agent "iMDT" for multidisciplinary joint consultations, serving 512 hospitals and empowering over 1,520 clinical doctors in complex medical diagnoses, significantly improving the decision quality of multidisciplinary teams (MDT) [1] Group 3: Pharmacy - The company has launched an intelligent agent for pharmacies, serving over 10,993 pharmacies, and established a matrix of five AI intelligent agents covering operational insights, products, diseases, memberships, and employees, as well as specialized AI for "individuals, families, diseases, and medications" to enhance store operations [1] Group 4: Health Management - The company has created a matrix of AI intelligent agents covering "individuals, families, diseases, and medications," accurately reaching over 3 million users, providing personalized health interventions and risk warnings, and constructing a comprehensive management system that includes prevention, screening, and intervention [1] Group 5: Business Transformation - The company has successfully transformed from a data technology service provider to an AI technology service provider, continuously optimizing its capabilities in "data + models + scenarios + ecosystem" to become the preferred AI service provider in the health industry [2]
中康控股(02361)AI大模型及AI智能体的商业化应用获显著进展 成功转型AI科技服务商